Skip to content
zameds

Amx

Amoxycillin

Every registration of this product has been cancelled.

Loading the molecular structure
C16H19N3O5S365.40 g/mol

(2S,5R,6R)-6-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 33613.

Registration

Applicants
1
Registrations
3

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Brovar S & P (Pty) LtdCancelledAmx250 mg, 500V0216, V0217, X0357Not determinedNone

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Amx 250*

EACH CAPSULE CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 250 mg

250V0216V/20.1.2/216CancelledNot determinedNone
Amx 500*

EACH CAPSULE CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 500 mg

500V0217V/20.1.2/217CancelledNot determinedNone
Amx 250 MG suspension*

EACH 5 ml SUSPENSION CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO 250 mg AMOXYCILLIN

250 mgSuspensionX0357X/20.1.2/357CancelledNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Background

Loading...
Loading Wikipedia summary

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Research articles

Loading...
Loading PubMed articles